Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 22 résultats.
    • Article de périodique
    Healthcare consumption and direct costs of rheumatoid arthritis in Belgium
    Westhovens, Rene[UCL] Durez, Patrick[UCL] Boonen, Anne[UCL] Verbruggen, L. De Clerck, L. Malaise, Michel Mielants, H. (2005) Clinical Rheumatology — Vol. 24, no. 6, p. 615-619 (2005)
    • Communication
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study
    Westhovens, Rene[UCL] Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Vastesaeger, N. (2004) Annual European Congress of Rheumatology (EULAR 2004) — Berlin (Germany)
    • Communication
    Are systemic inflammatory markers useful in the prediction of response to infliximab in Crohn's disease?
    Louis, EJ Vermeire, Severine[UCL] Rutgeerts, Paul[UCL] De Vos, M Van Gossum, A Pescatore, P Fiasse, René[UCL] Pelckmans, P Reynaert, H. D'Haens, G. Malaise, Michel Belaiche, J (2001) —
    • Article de périodique
    DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
    Cruyssen, BV Van Looy, S. Wyns, B Westhovens, Rene[UCL] Durez, Patrick[UCL] Van den Bosch, F. Veys, Éric M. Mielants, H. DE Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boullart, L. De Keyser, F. (2005) Arthritis Research & Therapy — Vol. 7, no. 5, p. R1063-R1071 (2005)
    • Communication
    Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Attrition and long-term clinical effect
    Cruyssen, B. Vander Durez, Patrick[UCL] Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaegere, N. Geldhof, A. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Article de périodique
    Timing of DAS28 in infliximab therapy: reply
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 9, p. 1204-1204 (2005)
    • Article de périodique
    Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
    Cruyssen, Bert Vander Van Looy, Stijn Wyns, Bart Westhovens, Rene Durez, Patrick[UCL] Van den Bosch, Filip Mielants, Herman De Clerck, Luc Peretz, Ann Malaise, Michel Verbruggen, Leon Vastesaeger, Nathan Geldhof, Anja Boullart, Luc De Keyser, Filip (2006) Arthritis Research & Therapy (Online) — Vol. 8, no. 4, p. R112 [1-7] (2006)
    • Communication
    OP0129 Effectiveness of COBRA-Slim with or without early access to a temporary 6-month course of etanercept in early RA: primary outcome of the 2-year, pragmatic, randomised CareRA2020 trial
    Bertrand, Delphine Joly, Johan Neerinckx, Barbara Durez, Patrick[UCL] Lenaerts, Jan Joos, Rik Thevissen, Kristof Zwaenepoel, Tom Geusens, Piet Méric De Bellefon, Laurent Taelman, Veerle Van Essche, Els Corluy, Lik Malaise, Michel Vanden Berghe, Marc Devink, Mieke Ajeganova, Sofia Durnez, Anne Boutsen, Yves[UCL] Margaux, Joëlle Peene, Isabelle Van Offel, Jan Doumen, Michaël Pazmino, Sofia De Meyst, Elias Westhovens, René Verschueren, Patrick (2023) EULAR 2023 European Congress of Rheumatology — (Italy) Milano
    • Article de périodique
    Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease
    Franchimont, N Putzeys, V Collette, J. Vermeire, Severine[UCL] Rutgeerts, Paul[UCL] De Vos, M Van Gossum, A Franchimont, D Fiasse, René[UCL] Pelckmans, P Malaise, Michel Belaiche, J Louis, E (2004) Alimentary Pharmacology and Therapeutics — Vol. 20, no. 6, p. 607-614 (2004)
    • Communication
    Long-term safety of infliximab (INX) with methotrexate (MTX) in a large belgian observational patient cohort with severe, refractory rheumatoid arthritis (RA)
    Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Vander Cruyssen, B. Vandenbosch, F. Vastesaeger, N. Geldhof, A. De Keyser, F. Verbruggen, L. De Clerck, L. Peretz, A. Malaise, Michel Van Heuverbeke, F. Westhovens, Rene[UCL] (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Communication
    Evaluation of the DAS28 at week 14 or week 22 correlates best with long term attrition to infliximab therapy in rheumatoid arthritis patients
    Cruyssen, B. Vander Durez, Patrick[UCL] Van Looy, S. Wijns, B. Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boullart, L. De Keyser, F. (2006) Annual European Congress of Rheumatology (EULAR 2006) — Amsterdam (Netherlands)
    • Communication
    Tapering infliximab dosages after temporary dose increase does not affect treatment survival in an established RA population
    Vander Cruyssen, B. Durez, Patrick[UCL] Westhovens, Rene[UCL] Van den Bosch, F. Mielants, H. De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Dewulf, L. Vastesaeger, N. Geldhof, A. Noel, W. Boullart, L.[UCL] De Keyser, F. (2008) —
    • Communication
    Das28 correlates best with the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients
    Vander Cruyssen, B. Durez, Patrick[UCL] Devogelaer, Jean-Pierre[UCL] Van Looy, S. Westhovens, Rene[UCL] Van den Bosch, F. Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Verbruggen, L. Vastesaeger, N. Geldhof, A. Boulart, L De Keyser, F. (2005) Annual European Congress of Rheumatology — Vienna (Austria)
    • Article de périodique
    An oleuropein-based dietary supplement may improve joint functional capacity in older people with high knee joint pain: findings from a multicentre-RCT and analysis.
    Horcajada, Marie-Noëlle Beaumont, Maurice Sauvageot, Nicolas Poquet, Laure Saboundjian, Madleen Costes, Berenice Verdonk, Peter Brands, Geoffrey Brasseur, Jean-Pierre[UCL] Urbin-Choffray, Didier Vandenberghe, Marc Brabants, Karl De Vlam, Kurt Fache, Werner Jandrain, Bernard Grek, Vincent Malaise, Michel Henrotin, Yves (2022) Therapeutic advances in musculoskeletal disease — Vol. 14, p. [1-15] (2022)
    • Article de périodique
    Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
    Henrotin, Yves Bannuru, Raveendhara Malaise, Michel Ea, Hang-Korng Confavreux, Cyrille Bentin, Jacques Urbin-Choffray, Didier Conrozier, Thierry BRASSEUR, Jean-Pierre[UCL] Thomas, Philippe Hick, Anne-Christine Marinello, Alessandro Giordan, Nicola Richette, Pascal (2019) BMC musculoskeletal disorders — Vol. 20, no. 1, p. 293 [1-16] (2019)
    • Article de périodique
    Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
    Henrotin, Yves Malaise, Michel Wittoek, Ruth de Vlam, Kurt Brasseur, Jean-Pierre[UCL] Luyten, Frank P Jiangang, Qu Van den Berghe, Marthe Uhoda, Raphaël Bentin, Jacques De Vroey, Thierry Erpicum, Luc Donneau, Anne F Dierckxsens, Yvan (2019) Arthritis research & therapy — Vol. 21, no. 1, p. 179 [1-10] (2019)
    • Article de périodique
    A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
    Durez, Patrick[UCL] Van den Bosch, F. Corluy, L Veys, Emilie[UCL] De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Vastesaeger, N. Geldhof, A. Westhovens, Rene[UCL] (2005) Rheumatology — Vol. 44, no. 4, p. 465-468 (2005)
    • Article de périodique
    Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment
    Ribbens, C Porras, MMY Franchimont, N Kaiser, MJ Jaspar, JM Damas, P. Houssiau, Frédéric[UCL] Malaise, Michel (2002) Annals of the Rheumatic Diseases — Vol. 61, no. 2, p. 161-166 (2002)
    • Article de périodique
    Efficacy of golimumab in Belgian patients with active rheumatoid arthritis despite treatment with non-biologic disease-modifying anti-rheumatic drugs: sub-analysis of the GO-MORE study
    Durez, Patrick[UCL] Vanthuyne, Marie[UCL] Soyfoo, Muhammad S. Hoffman, Ilse Malaise, Michel Geusens, Piet (2017) Acta Clinica Belgica — Vol. 72, no.6, p. 424-428 (2017)
    • Communication
    Safety of combination of methotrexate (MTX) and infliximab (IFX) in a large Belgian observational patient cohort with refractory rheumatoid arthritis.
    Durez, Patrick[UCL] Vandenbosch, F. Corluy, L Van den Bossche, N Schuerwegh, A De Clerck, L. Peretz, A. Malaise, Michel Devogelaer, Jean-Pierre[UCL] Westhovens, Rene[UCL] (2002) 66th Annual Scientific Meeting of the American-College-of-Rheumatology/37th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — NEW ORLEANS (Louisiana)
    • Communication
    Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.
    Cruyssen, Bert J. Vander Durez, Patrick[UCL] Westhovens, Rene Van den Bosch, Filip Mielants, Herman De Clerck, Luc Peretz, Ann Malaise, Michel Verbruggen, Leon Vastesaeger, Nathan Geldhof, Anja De Keyser, Filip (2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Washington (Dc)
    • Communication
    AB0169 Early remission at 6 months as a predictor of longterm remission in new onset rheumatoid arthritis
    Sapart, Emilie[UCL] Sokolova, Tatiana[UCL] Avramovska, Aleksandra[UCL] Sidiras, Paschalis Kleimberg, Sandra Dierckx, Stéphanie[UCL] Meric de Bellefon, Laurent[UCL] Ribbens, Clio Malaise, Michel Di Romana, Silvana Badot, Valerie Durez, Patrick[UCL] (2022) EULAR 2022 European Congress of Rheumatology — (Denmark) Copenhagen